Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
JW Pharmaceutical
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged between 18 and 80.
Dialysis for at least 3 months.
Epoetin treatment for the last 3 months.
Baseline hemoglobin (Hb) value of \>= 9.0 g/dL and \< 13.0 g/dL.
Baseline mean weekly epoetin maintenance dose ≤ 12,000 IU
Patients who agree to participate in this study in writing.
You may not be if
Hemoglobinopathies, i.e. sickle cell disease, thalassemia of all types.
Hemolysis as defined
Gastrointestinal bleeding necessitating treatment (medication, transfusion) within the last 3 months.
Patients with uncontrolled hypertension.
Acute infection of unstable systemic inflammatory disease.
Current malignant disease.
High likelihood of early withdrawal or interruption of the study (e.g. severe diseases within the last 3 months, such as myocardial infarction, unstable angina, stroke, deep venous thrombosis).
Life expectancy below 12 months.
Planned elective surgery during the study period.
Blood transfusions within the last 3 months.
Pregnancy and lactation.
Other conditions regarded as unsuitability by investigator.
